StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Ending Closing Price of NVS ADR on NYSE by Quarter

Ending Closing Price of NVS ADR on NYSE (USD/ADR) ($)

QuarterlyAnnual

Novartis Ending Closing Price of NVS ADR on NYSE: $143 in Q3 2026, up 11.2% from a year earlier.

Latest, Q3 2026
143
Period ended Sep 30, 2026
Change on a year earlier
+11.2%
128 in Q3 2025
History
36 quarters
Since Q4 2017
Sources
29
Documents cited below

Where the Q3 2026 figure comes from

“|| ADR price (USD) | 142.57 | 128.24”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEnding Closing Price of NVS ADR on NYSE (USD/ADR) ($)Year on yearSource
Q3 2026Sep 30, 2026143+11.2%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 2026157+29.5%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026153+37.0%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025138+41.7%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025128+11.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 2025121+13.7%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 2025111+15.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 202497.31-3.6%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 2024115+12.9%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 2024106+5.5%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 202496.73-4.2%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 2023101+11.3%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 2023102+34.0%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 2023101+19.4%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 2023101+15.1%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 202290.72+3.7%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Ending Closing Price of NVS ADR on NYSE ($), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/share-price-adr-usd

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.